<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1850">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04701515</url>
  </required_header>
  <id_info>
    <org_study_id>030.CVS.2020.D</org_study_id>
    <nct_id>NCT04701515</nct_id>
  </id_info>
  <brief_title>Cardiovascular Manifestations of COVID-19</brief_title>
  <official_title>Cardiovascular Manifestations of COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Methodist Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Methodist Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Electronic medical record review of de-identified patients who tested positive for COVID-19&#xD;
      (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020 until the date of&#xD;
      IRB approval. Data will be collected on de-identified patients that test positive for&#xD;
      COVID-19 (using a PCR test) at MDMC from the date of IRB approval until December 2022.&#xD;
      Disclaimer: Any cost associated with the procedures stated herein will be billed directly to&#xD;
      you or to your insurance (as applicable)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Electronic medical record review of de-identified patients who tested positive for COVID-19&#xD;
      (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020 until the date of&#xD;
      IRB approval. Data will be collected on de-identified patients that test positive for&#xD;
      COVID-19 (using a PCR test) at MDMC from the date of IRB approval until December 2022.&#xD;
      Variables include patient baseline characteristics, patient presentation, imaging and labs.&#xD;
      Disclaimer: Any cost associated with the procedures stated herein will be billed directly to&#xD;
      you or to your insurance (as applicable)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart failure</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tamponade</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pericardial Effusion</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocarditis</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pericarditis</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arrythmias</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Troponin I</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>N-terminal prohormone BNP</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Type</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shock</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep venous thrombosis</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Presence or absence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge disposition</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Location</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary diagnosis</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Diagnosis upon discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of ICU admission/transfer</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total hospital length of stay</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Number of Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Number of Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients in cohort that had EKG testing or Echocardiography</measure>
    <time_frame>March 2020 - June 2021</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Retrospective Cohort</arm_group_label>
    <description>Review electronic medical records of de-identified patients that tested positive for COVID-19 (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020 until December 2022</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chart review</intervention_name>
    <description>Chart review</description>
    <arm_group_label>Retrospective Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that test positive for COVID-19 (using a PCR test) at MDMC&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hospitalized patient&#xD;
&#xD;
          -  Adult over 18 years&#xD;
&#xD;
          -  Positive COVID-19 PCR Test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Manavjot Sidhu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Methodist Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Crystee Cooper, DHEd</last_name>
    <phone>214-947-1280</phone>
    <email>ClinicalResearch@mhd.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tammy Chan, PhD</last_name>
    <phone>214-947-1280</phone>
    <email>ClinicalResearch@mhd.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Methodist Dallas Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manavjot Sidhu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Chirag Patel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farukh Ikram, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicholas Nguyen, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 6, 2021</last_update_submitted>
  <last_update_submitted_qc>January 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

